Prospective Cohort Study to Evaluate Safety/Immunogenicity of Butantan Influenza Vaccine in Healthy Adults/Elderly

NCT02313740 · clinicaltrials.gov ↗

COMPLETED

Status

120

Enrollment

OTHER_GOV

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Butantan Fragmented Inactivated Trivalent Influenza Vaccine

Sponsor

Butantan Institute